A new review maps how mavacamten and aficamten are reshaping the treatment pathway for hypertrophic obstructive ...

Boron, though required only in minimal amounts, is vital for plant development. It strengthens cell walls and supports the growth of roots and shoots. Normally, boron, in the form of boric acid, is ...

Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, ...

Myosin VI is a molecular motor that can walk processively on actin filaments with a 36-nm step size. The walking mechanism of myosin VI is controversial because it takes very large steps without an ...

JUPITER, Fla., Sept. 16, 2026 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing a new class of therapies targeting cancer cell mechanics, today announced its ...

In its early stages, Alzheimer disease is increasingly recognized as a disease of synapses, those key mediators of memory storage in the brain. Enhancing synaptic function, therefore, might be a ...

"This process appears to be regulated by myosin-binding protein-C (cMyBP-C), which is a heart muscle protein," study author Kerry McDonald said. "Our study investigated its role in cardiac muscle ...

Discover the latest articles and news in related subjects. Crystals of this nucleotide-free myosin V construct diffracted to 2.0 Å. The refined structure is unlike that of any of the myosin structures ...

A team of biophysicists from the University of Massachusetts Amherst and Penn State College of Medicine set out to tackle the long-standing question about the nature of force generation by myosin, the ...